Back
MoonLake Immunotherapeutics Stock Predictions
Sponsored
MLTX
Sponsored
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Buy
83
MLTX
MoonLake Immunotherapeutics
Last Price:
53.18
Seasonality Move:
10.4%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.MoonLake Immunotherapeutics Stock Forecast
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 208.6% based on the past 3 years of stock performance.
- MoonLake Immunotherapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is MoonLake Immunotherapeutics Stock Undervalued?
The current MoonLake Immunotherapeutics [MLTX] share price is $53.02. The Score for MLTX is 83, which is 66% above its historic median score of 50, and infers lower risk than normal. - MLTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 208.6% based on the past 3 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Buy
83
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics overpriced?
- MoonLake Immunotherapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
64.98
52-Week Low:
35.11
Prediction Charts
Market Cap:
3.33B
Price in USD:
53.02
Volume:
663.08K
Beta:
1.27
Technical Analysis
SMA50:
46.50
SMA100:
44.00
SMA200:
48.46
52-Wk Change:
-8.03%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?
Yes, MoonLake Immunotherapeutics is a publicly traded company. -
What is the MoonLake Immunotherapeutics stock quote today?
The MoonLake Immunotherapeutics stock price is 53.02 USD today. -
How to buy MoonLake Immunotherapeutics stock online?
You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 46.70 | 47.48 | 47.66 | 46.57 |
Aug-30 | 47.78 | 46.73 | 47.78 | 46.50 |
Sep-3 | 46.65 | 46.31 | 48.65 | 45.76 |
Sep-4 | 46.09 | 47.41 | 48.35 | 45.91 |
Sep-5 | 47.09 | 45.58 | 47.25 | 45.27 |
Sep-6 | 45.53 | 46.01 | 46.05 | 44.71 |
Sep-9 | 46.35 | 46.76 | 47.19 | 46.23 |
Sep-10 | 46.94 | 46.60 | 47.18 | 45.31 |
Sep-11 | 46.50 | 46.47 | 46.68 | 45.40 |
Sep-12 | 47.00 | 50.99 | 51.95 | 46.80 |
Sep-13 | 51.10 | 51.14 | 52.71 | 50.25 |
Sep-16 | 51.54 | 49.98 | 51.61 | 49.97 |
Sep-17 | 49.99 | 50.99 | 51.09 | 47.70 |
Sep-18 | 51.49 | 53.02 | 55.05 | 51.27 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.79 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.